SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
SmartTRAK reports that Q322 Spine Market performance drove a lack of consensus on operational performanc...
SmartTRAK takes a look back at Neuromodulation Trends in 2022 and looks forward to reporting on emerging...
Biosynthetic hernia matrices continue their ascent and Xenograft hernia matrices grow, thanks to TELA Bi...
Despite declining OUS results, the US Trauma Market experienced healthy growth attributed to adoption of...
Growth in the SCS and DBS segments remained soft in Q322 as companies continue to wrestle with macro-env...
Surgeons are concerned about the cost of breast matrices in an increasingly restrictive environment, but...
Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under...
CMS Reimbursement changes raging like a beast to belabor several HA market players For Q322, the true im...
As the CEO of SmartTRAK, I understand Medtech executives often drown in data and need quick, easy access...
SmartTRAK interviews Bolt Navigation CEO Patrick West to learn more about the Company and its potentiall...
Login